Evolving progress in oncologic and operative outcomes for esophageal and junctional cancer: lessons from the experience of a high-volume center.

Reynolds, John V; Donohoe, Claire L; McGillycuddy, Erin; Ravi, Naraymasamy; O'Toole, Dermot; O'Byrne, Ken; Hollywood, Donal

Name:

Publisher version

Authors

Reynolds, John V
Donohoe, Claire L
McGillycuddy, Erin
Ravi, Naraymasamy
O'Toole, Dermot
O'Byrne, Ken
Hollywood, Donal

Affiliation

Department of Surgery, St James's Hospital and Trinity College, Dublin, Ireland. reynoljv@tcd.ie

Issue Date

2012-05

Keywords

Carcinoma, Squamous Cell/therapy
Esophageal Neoplasms/therapy
Esophagogastric Junction/surgery
Adenocarcinoma/therapy

MeSH

Adenocarcinoma
Age Factors
Carcinoma, Squamous Cell
Chemoradiotherapy, Adjuvant
Chi-Square Distribution
Disease-Free Survival
Esophageal Neoplasms
Esophagectomy
Esophagogastric Junction
Gastrectomy

Show all

Metadata

Show full item record

Citation

Evolving progress in oncologic and operative outcomes for esophageal and junctional cancer: lessons from the experience of a high-volume center. 2012, 143 (5):1130-1137.e1 J. Thorac. Cardiovasc. Surg.

Publisher

Elsevier

Journal

The Journal of thoracic and cardiovascular surgery

URI

http://hdl.handle.net/10147/243783

DOI

10.1016/j.jtcvs.2011.12.003

PubMed ID

22244551

Abstract

Modern series from high-volume esophageal centers report an approximate 40% 5-year survival in patients treated with curative intent and postoperative mortality rates of less than 4%. An objective analysis of factors that underpin current benchmarks within high-volume centers has not been performed.